nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluphenazine—CYP1A2—Carmustine—lymphatic system cancer	0.218	0.373	CbGbCtD
Fluphenazine—CYP2E1—Mitoxantrone—lymphatic system cancer	0.177	0.304	CbGbCtD
Fluphenazine—ABCB1—Mitoxantrone—lymphatic system cancer	0.0897	0.153	CbGbCtD
Fluphenazine—ABCB1—Vincristine—lymphatic system cancer	0.0617	0.106	CbGbCtD
Fluphenazine—ABCB1—Methotrexate—lymphatic system cancer	0.0374	0.064	CbGbCtD
Fluphenazine—Edema cerebral—Carmustine—lymphatic system cancer	0.0317	0.0763	CcSEcCtD
Fluphenazine—Hypotensive—Teniposide—lymphatic system cancer	0.0239	0.0575	CcSEcCtD
Fluphenazine—Brain oedema—Carmustine—lymphatic system cancer	0.0172	0.0413	CcSEcCtD
Fluphenazine—Seborrhoeic dermatitis—Fludarabine—lymphatic system cancer	0.0112	0.0271	CcSEcCtD
Fluphenazine—Ileus paralytic—Vincristine—lymphatic system cancer	0.0108	0.0261	CcSEcCtD
Fluphenazine—Pancytopenia—Mechlorethamine—lymphatic system cancer	0.00705	0.017	CcSEcCtD
Fluphenazine—Tenderness—Bleomycin—lymphatic system cancer	0.00644	0.0155	CcSEcCtD
Fluphenazine—Agranulocytosis—Mechlorethamine—lymphatic system cancer	0.00618	0.0149	CcSEcCtD
Fluphenazine—Leukocytosis—Carmustine—lymphatic system cancer	0.00522	0.0126	CcSEcCtD
Fluphenazine—Pancytopenia—Teniposide—lymphatic system cancer	0.0052	0.0125	CcSEcCtD
Fluphenazine—Dysphagia—Fludarabine—lymphatic system cancer	0.00481	0.0116	CcSEcCtD
Fluphenazine—Leukopenia—Mechlorethamine—lymphatic system cancer	0.00463	0.0111	CcSEcCtD
Fluphenazine—Pancytopenia—Fludarabine—lymphatic system cancer	0.00457	0.011	CcSEcCtD
Fluphenazine—Appetite absent—Methotrexate—lymphatic system cancer	0.00457	0.011	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Fludarabine—lymphatic system cancer	0.00447	0.0108	CcSEcCtD
Fluphenazine—Gynaecomastia—Carmustine—lymphatic system cancer	0.00439	0.0106	CcSEcCtD
Fluphenazine—Pneumonia—Fludarabine—lymphatic system cancer	0.00431	0.0104	CcSEcCtD
Fluphenazine—Urine output increased—Vincristine—lymphatic system cancer	0.00424	0.0102	CcSEcCtD
Fluphenazine—Anaphylactic shock—Mechlorethamine—lymphatic system cancer	0.00422	0.0102	CcSEcCtD
Fluphenazine—Skin disorder—Mechlorethamine—lymphatic system cancer	0.0041	0.00987	CcSEcCtD
Fluphenazine—Polyuria—Vincristine—lymphatic system cancer	0.00387	0.00932	CcSEcCtD
Fluphenazine—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.00367	0.00883	CcSEcCtD
Fluphenazine—Renal failure acute—Mitoxantrone—lymphatic system cancer	0.00359	0.00863	CcSEcCtD
Fluphenazine—Agitation—Teniposide—lymphatic system cancer	0.0035	0.00843	CcSEcCtD
Fluphenazine—Anaphylactoid reaction—Mitoxantrone—lymphatic system cancer	0.00342	0.00823	CcSEcCtD
Fluphenazine—Leukopenia—Teniposide—lymphatic system cancer	0.00341	0.00821	CcSEcCtD
Fluphenazine—Pancytopenia—Bleomycin—lymphatic system cancer	0.00335	0.00806	CcSEcCtD
Fluphenazine—Hypertension—Teniposide—lymphatic system cancer	0.00329	0.00792	CcSEcCtD
Fluphenazine—Cardiac arrest—Vincristine—lymphatic system cancer	0.00323	0.00778	CcSEcCtD
Fluphenazine—Pneumonia—Bleomycin—lymphatic system cancer	0.00316	0.00761	CcSEcCtD
Fluphenazine—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.00311	0.00748	CcSEcCtD
Fluphenazine—Agitation—Fludarabine—lymphatic system cancer	0.00308	0.00741	CcSEcCtD
Fluphenazine—Dysphagia—Carmustine—lymphatic system cancer	0.00308	0.00741	CcSEcCtD
Fluphenazine—Tachycardia—Teniposide—lymphatic system cancer	0.00304	0.00731	CcSEcCtD
Fluphenazine—Leukopenia—Fludarabine—lymphatic system cancer	0.003	0.00722	CcSEcCtD
Fluphenazine—Pruritus—Mechlorethamine—lymphatic system cancer	0.00299	0.00719	CcSEcCtD
Fluphenazine—Pancytopenia—Carmustine—lymphatic system cancer	0.00292	0.00703	CcSEcCtD
Fluphenazine—Hypotension—Teniposide—lymphatic system cancer	0.00291	0.007	CcSEcCtD
Fluphenazine—Pancytopenia—Vincristine—lymphatic system cancer	0.00279	0.00672	CcSEcCtD
Fluphenazine—Dyspnoea—Teniposide—lymphatic system cancer	0.00277	0.00668	CcSEcCtD
Fluphenazine—Pneumonia—Carmustine—lymphatic system cancer	0.00276	0.00664	CcSEcCtD
Fluphenazine—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.00274	0.00658	CcSEcCtD
Fluphenazine—Pancytopenia—Mitoxantrone—lymphatic system cancer	0.00272	0.00654	CcSEcCtD
Fluphenazine—Decreased appetite—Teniposide—lymphatic system cancer	0.00271	0.00651	CcSEcCtD
Fluphenazine—Photosensitivity reaction—Vincristine—lymphatic system cancer	0.00268	0.00645	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Mitoxantrone—lymphatic system cancer	0.00266	0.0064	CcSEcCtD
Fluphenazine—Pneumonia—Vincristine—lymphatic system cancer	0.00264	0.00634	CcSEcCtD
Fluphenazine—Pneumonia—Mitoxantrone—lymphatic system cancer	0.00257	0.00618	CcSEcCtD
Fluphenazine—Drowsiness—Mitoxantrone—lymphatic system cancer	0.00255	0.00614	CcSEcCtD
Fluphenazine—Nausea—Mechlorethamine—lymphatic system cancer	0.00251	0.00603	CcSEcCtD
Fluphenazine—Urticaria—Teniposide—lymphatic system cancer	0.00247	0.00595	CcSEcCtD
Fluphenazine—Body temperature increased—Teniposide—lymphatic system cancer	0.00246	0.00592	CcSEcCtD
Fluphenazine—Erythema—Bleomycin—lymphatic system cancer	0.00246	0.00591	CcSEcCtD
Fluphenazine—Dyspnoea—Fludarabine—lymphatic system cancer	0.00244	0.00587	CcSEcCtD
Fluphenazine—Oedema peripheral—Carmustine—lymphatic system cancer	0.00243	0.00584	CcSEcCtD
Fluphenazine—Agranulocytosis—Mitoxantrone—lymphatic system cancer	0.00238	0.00573	CcSEcCtD
Fluphenazine—Decreased appetite—Fludarabine—lymphatic system cancer	0.00238	0.00572	CcSEcCtD
Fluphenazine—Constipation—Fludarabine—lymphatic system cancer	0.00234	0.00563	CcSEcCtD
Fluphenazine—Hypersensitivity—Teniposide—lymphatic system cancer	0.00229	0.00552	CcSEcCtD
Fluphenazine—Pruritus—Teniposide—lymphatic system cancer	0.0022	0.0053	CcSEcCtD
Fluphenazine—Leukopenia—Bleomycin—lymphatic system cancer	0.0022	0.00529	CcSEcCtD
Fluphenazine—Body temperature increased—Fludarabine—lymphatic system cancer	0.00216	0.0052	CcSEcCtD
Fluphenazine—Erythema—Carmustine—lymphatic system cancer	0.00215	0.00516	CcSEcCtD
Fluphenazine—Urine output increased—Methotrexate—lymphatic system cancer	0.00205	0.00494	CcSEcCtD
Fluphenazine—Gynaecomastia—Methotrexate—lymphatic system cancer	0.00203	0.00489	CcSEcCtD
Fluphenazine—Vision blurred—Carmustine—lymphatic system cancer	0.00202	0.00486	CcSEcCtD
Fluphenazine—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00202	0.00485	CcSEcCtD
Fluphenazine—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.00201	0.00483	CcSEcCtD
Fluphenazine—Erythema—Mitoxantrone—lymphatic system cancer	0.00199	0.0048	CcSEcCtD
Fluphenazine—Agitation—Carmustine—lymphatic system cancer	0.00197	0.00474	CcSEcCtD
Fluphenazine—Headache—Teniposide—lymphatic system cancer	0.00195	0.00469	CcSEcCtD
Fluphenazine—Pruritus—Fludarabine—lymphatic system cancer	0.00194	0.00466	CcSEcCtD
Fluphenazine—Leukopenia—Carmustine—lymphatic system cancer	0.00192	0.00462	CcSEcCtD
Fluphenazine—Agitation—Vincristine—lymphatic system cancer	0.00188	0.00453	CcSEcCtD
Fluphenazine—Vision blurred—Mitoxantrone—lymphatic system cancer	0.00188	0.00452	CcSEcCtD
Fluphenazine—Polyuria—Methotrexate—lymphatic system cancer	0.00188	0.00452	CcSEcCtD
Fluphenazine—Photosensitivity—Methotrexate—lymphatic system cancer	0.00188	0.00452	CcSEcCtD
Fluphenazine—Hypotension—Bleomycin—lymphatic system cancer	0.00187	0.00451	CcSEcCtD
Fluphenazine—Hypertension—Carmustine—lymphatic system cancer	0.00185	0.00446	CcSEcCtD
Fluphenazine—Nausea—Teniposide—lymphatic system cancer	0.00185	0.00445	CcSEcCtD
Fluphenazine—Leukopenia—Vincristine—lymphatic system cancer	0.00183	0.00441	CcSEcCtD
Fluphenazine—Dyspnoea—Bleomycin—lymphatic system cancer	0.00179	0.0043	CcSEcCtD
Fluphenazine—Renal failure acute—Methotrexate—lymphatic system cancer	0.00179	0.0043	CcSEcCtD
Fluphenazine—Leukopenia—Mitoxantrone—lymphatic system cancer	0.00179	0.0043	CcSEcCtD
Fluphenazine—Hypertension—Vincristine—lymphatic system cancer	0.00177	0.00425	CcSEcCtD
Fluphenazine—Dermatitis exfoliative—Methotrexate—lymphatic system cancer	0.00175	0.00421	CcSEcCtD
Fluphenazine—Decreased appetite—Bleomycin—lymphatic system cancer	0.00174	0.00419	CcSEcCtD
Fluphenazine—Hypertension—Mitoxantrone—lymphatic system cancer	0.00172	0.00414	CcSEcCtD
Fluphenazine—Headache—Fludarabine—lymphatic system cancer	0.00171	0.00412	CcSEcCtD
Fluphenazine—Tachycardia—Carmustine—lymphatic system cancer	0.00171	0.00411	CcSEcCtD
Fluphenazine—Anaphylactoid reaction—Methotrexate—lymphatic system cancer	0.0017	0.0041	CcSEcCtD
Fluphenazine—Lethargy—Methotrexate—lymphatic system cancer	0.00168	0.00405	CcSEcCtD
Fluphenazine—Anaphylactic shock—Vincristine—lymphatic system cancer	0.00167	0.00402	CcSEcCtD
Fluphenazine—Hypotension—Carmustine—lymphatic system cancer	0.00164	0.00394	CcSEcCtD
Fluphenazine—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.00163	0.00392	CcSEcCtD
Fluphenazine—Nausea—Fludarabine—lymphatic system cancer	0.00162	0.00391	CcSEcCtD
Fluphenazine—Urticaria—Bleomycin—lymphatic system cancer	0.00159	0.00383	CcSEcCtD
Fluphenazine—Tachycardia—Mitoxantrone—lymphatic system cancer	0.00159	0.00382	CcSEcCtD
Fluphenazine—Body temperature increased—Bleomycin—lymphatic system cancer	0.00159	0.00381	CcSEcCtD
Fluphenazine—Skin disorder—Mitoxantrone—lymphatic system cancer	0.00158	0.0038	CcSEcCtD
Fluphenazine—Hypotension—Vincristine—lymphatic system cancer	0.00156	0.00376	CcSEcCtD
Fluphenazine—Dyspnoea—Carmustine—lymphatic system cancer	0.00156	0.00376	CcSEcCtD
Fluphenazine—Somnolence—Carmustine—lymphatic system cancer	0.00156	0.00374	CcSEcCtD
Fluphenazine—Decreased appetite—Carmustine—lymphatic system cancer	0.00152	0.00366	CcSEcCtD
Fluphenazine—Hypotension—Mitoxantrone—lymphatic system cancer	0.00152	0.00366	CcSEcCtD
Fluphenazine—Constipation—Carmustine—lymphatic system cancer	0.0015	0.0036	CcSEcCtD
Fluphenazine—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00148	0.00356	CcSEcCtD
Fluphenazine—Decreased appetite—Vincristine—lymphatic system cancer	0.00145	0.0035	CcSEcCtD
Fluphenazine—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00145	0.00349	CcSEcCtD
Fluphenazine—Somnolence—Mitoxantrone—lymphatic system cancer	0.00145	0.00348	CcSEcCtD
Fluphenazine—Constipation—Vincristine—lymphatic system cancer	0.00143	0.00344	CcSEcCtD
Fluphenazine—Asthma—Methotrexate—lymphatic system cancer	0.00143	0.00343	CcSEcCtD
Fluphenazine—Pruritus—Bleomycin—lymphatic system cancer	0.00142	0.00341	CcSEcCtD
Fluphenazine—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00141	0.0034	CcSEcCtD
Fluphenazine—Eosinophilia—Methotrexate—lymphatic system cancer	0.00141	0.0034	CcSEcCtD
Fluphenazine—Constipation—Mitoxantrone—lymphatic system cancer	0.00139	0.00335	CcSEcCtD
Fluphenazine—Body temperature increased—Carmustine—lymphatic system cancer	0.00138	0.00333	CcSEcCtD
Fluphenazine—Pancytopenia—Methotrexate—lymphatic system cancer	0.00135	0.00326	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.00133	0.00319	CcSEcCtD
Fluphenazine—Body temperature increased—Vincristine—lymphatic system cancer	0.00132	0.00318	CcSEcCtD
Fluphenazine—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.0013	0.00313	CcSEcCtD
Fluphenazine—Urticaria—Mitoxantrone—lymphatic system cancer	0.00129	0.00311	CcSEcCtD
Fluphenazine—Hypersensitivity—Carmustine—lymphatic system cancer	0.00129	0.0031	CcSEcCtD
Fluphenazine—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00129	0.0031	CcSEcCtD
Fluphenazine—Pneumonia—Methotrexate—lymphatic system cancer	0.00128	0.00308	CcSEcCtD
Fluphenazine—Drowsiness—Methotrexate—lymphatic system cancer	0.00127	0.00306	CcSEcCtD
Fluphenazine—Hypersensitivity—Vincristine—lymphatic system cancer	0.00123	0.00296	CcSEcCtD
Fluphenazine—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.0012	0.00289	CcSEcCtD
Fluphenazine—Nausea—Bleomycin—lymphatic system cancer	0.00119	0.00287	CcSEcCtD
Fluphenazine—Agranulocytosis—Methotrexate—lymphatic system cancer	0.00119	0.00285	CcSEcCtD
Fluphenazine—Headache—Carmustine—lymphatic system cancer	0.0011	0.00264	CcSEcCtD
Fluphenazine—Headache—Vincristine—lymphatic system cancer	0.00105	0.00252	CcSEcCtD
Fluphenazine—Nausea—Carmustine—lymphatic system cancer	0.00104	0.0025	CcSEcCtD
Fluphenazine—Headache—Mitoxantrone—lymphatic system cancer	0.00102	0.00245	CcSEcCtD
Fluphenazine—Erythema—Methotrexate—lymphatic system cancer	0.000994	0.00239	CcSEcCtD
Fluphenazine—Nausea—Vincristine—lymphatic system cancer	0.000993	0.00239	CcSEcCtD
Fluphenazine—Nausea—Mitoxantrone—lymphatic system cancer	0.000967	0.00233	CcSEcCtD
Fluphenazine—Vision blurred—Methotrexate—lymphatic system cancer	0.000936	0.00225	CcSEcCtD
Fluphenazine—Leukopenia—Methotrexate—lymphatic system cancer	0.000889	0.00214	CcSEcCtD
Fluphenazine—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000811	0.00195	CcSEcCtD
Fluphenazine—Skin disorder—Methotrexate—lymphatic system cancer	0.000788	0.0019	CcSEcCtD
Fluphenazine—Hypotension—Methotrexate—lymphatic system cancer	0.000758	0.00182	CcSEcCtD
Fluphenazine—Dyspnoea—Methotrexate—lymphatic system cancer	0.000723	0.00174	CcSEcCtD
Fluphenazine—Somnolence—Methotrexate—lymphatic system cancer	0.000721	0.00173	CcSEcCtD
Fluphenazine—Decreased appetite—Methotrexate—lymphatic system cancer	0.000705	0.0017	CcSEcCtD
Fluphenazine—Urticaria—Methotrexate—lymphatic system cancer	0.000644	0.00155	CcSEcCtD
Fluphenazine—Body temperature increased—Methotrexate—lymphatic system cancer	0.000641	0.00154	CcSEcCtD
Fluphenazine—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000597	0.00144	CcSEcCtD
Fluphenazine—Pruritus—Methotrexate—lymphatic system cancer	0.000574	0.00138	CcSEcCtD
Fluphenazine—Headache—Methotrexate—lymphatic system cancer	0.000508	0.00122	CcSEcCtD
Fluphenazine—Nausea—Methotrexate—lymphatic system cancer	0.000482	0.00116	CcSEcCtD
